Sunstone Life Science Ventures is an independent European venture capital investment firm focused on early-stage life science companies developing novel therapeutics for humans. Their primary goal is to transform innovative scientific discoveries into valuable new products that enhance patient outcomes and generate returns for innovators, investors, and healthcare systems. The firm seeks to identify, enable, and empower the most promising therapeutics innovations, contributing to bringing new drugs into the market and supporting numerous clinical trials. They invest across preclinical drug candidates through new drugs approved for market.
Bevorzugte Reifephase für die erste Finanzierung.
Therapeutics, Biotechnology, Pharmaceuticals, Life Science
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...